Search


	Podcast:		The Bio Report
	Episode:		Will a Focus on Protein Dysregulation Help Prothena Break from the Fold
	Category:		Business
	Duration:		00:35:54
	Publish Date:		2020-09-03 04:00:27
	Description:		The complexity of neurodegenerative diseases has made it a challenging area for drug developers. Gene Kinney, CEO of Prothena, has long been involved in the pursuit of therapies for diseases such as Alzheimer’s and believes there has been great progress in understanding and targeting these conditions. In fact, he says we are entering a golden age of neuroscience. We spoke to Kinney about the state of drug development for neurodegenerative conditions, Prothena’s pipeline, and its effort to target protein dysregulation in these diseases.
	Total Play:		0

Some more Podcasts by Levine Media Group

600+ Episodes

The Bio Repo ..